Search Ontology:
ChEBI

zipalertinib

Term ID
CHEBI:233402
Synonyms
  • (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido(5,4-b)indolizin-8-yl)acrylamide
  • CLN 081
  • CLN-081
  • CLN081
  • N-[(8S)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
  • TAS 6417
  • TAS-6417
  • TAS6417
  • TPC 064
  • TPC-064
  • TPC064
  • zipalertinib
  • zipalertinibum
Definition
A member of the class of acrylamides that is (8S)-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizine-4,8-diamine in which the amino group at position 8S is substituted by an acryloyl group. It a covalent epidermal growth factor receptor inhibitor that targets exon 20 insertion mutations.
References
  • cas:1661854-97-2
  • drugbank:DB18763
  • pdb-ccd:X9H
  • pubmed:29748209
  • pubmed:31467113
  • pubmed:36324498
  • pubmed:36380577
  • pubmed:36915628
  • pubmed:37384848
  • pubmed:37487151
  • pubmed:37669428
  • pubmed:38229766
  • pubmed:38770784
  • pubmed:39417568
  • pubmed:39471218
  • wikipedia.en:Zipalertinib
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from zipalertinib
Phenotype where environments contain zipalertinib
Phenotype modified by environments containing zipalertinib
Phenotype affecting zipalertinib
Human Disease Model